Evidence map›Paper›PMID 22888249›Full record

ArticleInternational journal of nanomedicine2012

The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs).

Haitham Amal, Lu Ding, Bin-bin Liu, Ulrike Tisch, Zhen-qin Xu, Da-you Shi, Yan Zhao, Jie Chen, Rui-xia Sun, Hu Liu and 3 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03958812 unknown statusnot on this mapstarted 2019, after this paper: background citation

The Diagnostic Power of VOCs Compared With CTCs for Cancer

TypeobservationalSponsorAnhui Medical UniversityRan2019 to 2020Enrolled200ConditionsCirculating Tumor Cell, Volatile Organic Chemicals, Breast Cancer, Gastric CancerArmsCirculating tumor cells, Volatile organic compounds
NCT03967652 unknown statusnot on this mapstarted 2019, after this paper: background citation

Diagnosing Cancers From Healthy From Human Exhaled Breath With Na-nose

TypeobservationalSponsorAnhui Medical UniversityRan2019 to 2022Enrolled10,000ConditionsVolatile Organic Compounds, Cancer, Diagnoses DiseaseArmsNanomaterial-based sensors
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Highly Adsorptive Au-TiOACS applied materials & interfaces · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Raman Spectroscopy: A Novel Technology for Gastric Cancer Diagnosis.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Carbon Nanotube Chemical Sensors.Chemical reviews · 2019
    Review
  16. Article
  17. A Prediction Model with a Combination of Variables for Diagnosis of Lung Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  18. Article
  19. Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Haitham AmalDepartment of Chemical Engineering and Russell Berrie Nanotechnology Institute, Technion - Israel Institute of Technology, Haifa, Israel.
Lu Ding
Bin-bin Liu
Ulrike Tisch
Zhen-qin Xu
Da-you Shi
Yan Zhao
Jie Chen
Rui-xia Sun
Hu Liu
Sheng-Long Ye
Zhao-you Tang
Hossam Haick
Fudan University · CNTechnion – Israel Institute of Technology · ILAnhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) is a common and aggressive form of cancer. Due to a high rate of postoperative recurrence, the prognosis for HCC is poor. Subclinical metastasis is the major cause of tumor recurrence and patient mortality. Currently, there is no reliable prognostic method of invasion.

aimTo investigate the feasibility of fingerprints of volatile organic compounds (VOCs) for the in-vitro prediction of metastasis.

methodsHeadspace gases were collected from 36 cell cultures (HCC with high and low metastatic potential and normal cells) and analyzed using nanomaterial-based sensors. Predictive models were built by employing discriminant factor analysis pattern recognition, and the classification success was determined using leave-one-out cross-validation. The chemical composition of each headspace sample was studied using gas chromatography coupled with mass spectrometry (GC-MS).

resultsExcellent discrimination was achieved using the nanomaterial-based sensors between (i) all HCC and normal controls; (ii) low metastatic HCC and normal controls; (iii) high metastatic HCC and normal controls; and (iv) high and low HCC. Several HCC-related VOCs that could be associated with biochemical cellular processes were identified through GC-MS analysis.

conclusionThe presented results constitute a proof-of-concept for the in-vitro prediction of the metastatic potential of HCC from VOC fingerprints using nanotechnology. Further studies on a larger number of more diverse cell cultures are needed to evaluate the robustness of the VOC patterns. These findings could benefit the development of a fast and potentially inexpensive laboratory test for subclinical HCC metastasis.

Indexed as

AnimalsBiomarkers, TumorCarcinoma, HepatocellularCase-Control StudiesCell Line, TumorDiscriminant AnalysisGas Chromatography-Mass SpectrometryHep G2 CellsHumansLiver NeoplasmsLung NeoplasmsMiceMice, NudeModels, TheoreticalNanotechnologyNeoplasm MetastasisBiomarkers, TumorVolatile Organic CompoundsGC-MShepatocarcinomametastasissensorvolatile organic compound

Identifiers

PMID22888249
PMCPMC3415321
OpenAlexW1911099082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.